decisionhealth Newsletters, Part B News - 2002 Issue 9 (September)
MedPAC poised to recommend alternatives to drug pricing system
Subscribe or sign in to view the full article.
Article Overview
This article examines MedPAC’s consideration of changes to Medicare Part B drug payment policy, including concerns raised by commissioners, references to CMS authority, and legislative interest in revising the reimbursement framework. It is relevant to coders, billing professionals, compliance staff, and policy readers who track Medicare payment methodology, physician practice expenses, and drug pricing reform. The article outlines several broad alternative payment approaches under discussion without serving as a coding instruction piece.
Why This Topic Matters
Changes to Medicare drug reimbursement can affect physician payment, practice economics, beneficiary cost sharing, and compliance expectations across specialties that furnish Part B drugs. Readers need to understand the policy options being discussed because they may lead to administrative or legislative changes that affect reimbursement workflows and payment calculations.
What You Will Learn
- Why MedPAC is discussing changes to Medicare Part B drug reimbursement
- What broad payment alternatives are being considered by CMS and Congress
- How practice expense concerns factor into the policy discussion
- Why the issue matters to physician specialties that furnish drugs
Who Should Read This
- Medical coders
- Billing specialists
- Compliance professionals
- Practice managers
- Healthcare policy analysts
- Physician group administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com